1. Van Baarlen P, et al. “Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways.”
Proc Natl Acad Sci USA. 2011;108 Suppl 1:4562-4569.
2. Fragiadakis GK, et al. “Links between environment, diet, and the hunter-gatherer microbiome.” Gut Microbes. 2018:1-12.
3. Horosheva TV, et al. “Efficacy of Bacillus probiotics in prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled clinical trial.” JMM Case Reports. 2014;1.
4. Liu UP, et al. Zhonghua Yi Xue Za Zhi. 2012 Nov
5. Tompkins TA, et al. Beneficial Microbes. 2010.
6. Hoa TT, et al. “Fate and dissemination of Bacillus subtilis spores in a murine model.” App Environ Microbial. 2001;67(9):3819-3823.
7. Zhang HL, et al. “Mucosa-repairing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice.” Exp Ther Med. 2016;12(4):2554-2562.
8. Hatanaka M, et al. “Influence of Bacillus subtilis C-3102 on microbiota in a dynamic in vitro model of the gastrointestinal tract simulating human conditions.” Benef Microbes. 2012;3(3):229-236.
9. Hosoi T, et al. “Improved growth and viability of lactobacilli in the presence of Bacillus subtilis (natto), catalase, or subtilisin.” Can J Microbiol. 2000;46(10):892-897.
10. Sanchez M, et al. “Effect of lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women.” Br J Nutr. 2014;111(8):1507-1519.
11. Science Daily. “Probiotics may help ward off obesity, study in pregnant women suggests.” European Association for the Study of Obesity. May 8, 2009.
12. Mekkes MC, et al. “The development of probiotic treatment in obesity: A review.” Benef Microbes. 2014;5(1):19-28.
13. Luedde M, et al. “Heart failure is associated with depletion of core intestinal microbiota.” ESC Heart Fail. 2017;4(3):282-290.
14. Tang WH, et al. “Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: Refining the gut hypothesis.” J Am Coll Cardiol. 2014;64(18):1908-1914.
15. Gilani AH, et al. “Antispasmodic effects of Rooibos tea (Aspalathus linearis) is mediated predominantly through K+ -Channel Activation.” Basic Clin Pharmacol Toxicol. 2006;99(5):365-373.
16. Abou-Donia MB, et al. “Splenda alters gut microflora and increases intestinal p-glycoprotein and cyctochrome p-450 in male rats.” J Toxicol Environ Health A. 2008;71(21):1415-1429.
17. Mawdsley JE and Ramptom DS. “Psychological stress in IBD: New insights into pathogenic and therapeutic implications.” Gut. 2005;54(10):1481-1491.
18. Collins SM and Bercik P. “The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease.” Gastroenterology. 2009;136(6):2003-2014.
19. Cryan JF and O’Mahony SM. “The microbiome-gut-brain axis: From bowel to behavior.” Neurogastroenterol Motil. 2011;23(3):187-192.
20. Dash S, et al. “The gut microbiome and diet in psychiatry: Focus on depression.” Curr Opin Psychiatry. 2015;28(1):1-6.
21. Lee DE, et al. “Clinical evidence of effects of lactobacillus plantarum HY7714 on skin aging: A randomized, double blind, placebo-controlled study.” J Microbiol Biotechnol. 2015;25(12):2160-2168.